Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- AstraZeneca Plc (NASDAQ: AZN) said that China’s health regulator had expanded the use of Tagrisso in patients with a type of lung cancer when diagnosed at an early stage.
- China’s National Medical Products Administration (NMPA) approved Tagrisso as adjuvant therapy for early-stage lung cancer patients who have a mutation of the EGFR gene.
- The drug is now approved to treat early-stage lung cancer in more than a dozen countries, including, most recently, in the United States.
- The Chinese approval was based on positive results from a late-stage trial that showed Tagrisso cut the risk of disease recurrence or death by 83%.
- Price Action: AZN shares are up 1.46% at $49.91 in premarket trading on the last check Wednesday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!